{"id":208410,"date":"2017-02-16T17:53:52","date_gmt":"2017-02-16T22:53:52","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/why-fortress-investment-group-editas-medicine-and-hertz-global-holdings-jumped-today-motley-fool.php"},"modified":"2017-02-16T17:53:52","modified_gmt":"2017-02-16T22:53:52","slug":"why-fortress-investment-group-editas-medicine-and-hertz-global-holdings-jumped-today-motley-fool","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/why-fortress-investment-group-editas-medicine-and-hertz-global-holdings-jumped-today-motley-fool.php","title":{"rendered":"Why Fortress Investment Group, Editas Medicine, and Hertz Global Holdings Jumped Today &#8211; Motley Fool"},"content":{"rendered":"<p><p>    The stock market continued to    climb sharply on Wednesday, sending major market benchmarks to    record highs yet again and propelling the Dow Jones    Industrials up more than 100 points. Economic data    continued to support the notion that the U.S. economy remains    strong, and rising inflation levels led many to conclude that    the Federal Reserve is more likely than ever to follow through    on its promise to keep lifting short-term interest rates in    2017. Rising bond yields reflected investors' reluctance to    hold onto fixed-income investments in anticipation of higher    rates, prompting some to shift assets into the stock market.    Several companies also reported, andFortress    Investment Group (NYSE:FIG),    Editas Medicine (NASDAQ:EDIT),    and Hertz Global Holdings (NYSE:HTZ)    were among the top performers on the day. Below, we'll look    more closely at these stocks to tell you why they did so    well.  <\/p>\n<p>    Shares of Fortress Investment Group soared almost 30% after the    investment specialist received a takeover bid from Japan's    SoftBank. The terms of the $3.3 billion buyout    involve Fortress Class A shareholders receiving cash of $8.08    per share, and in addition, shareholders will be entitled to    receive dividend payments for the fourth quarter of 2016 and    the first quarter of 2017 if the transaction doesn't close    before the latter payment is due. As part of the deal, key    leaders at Fortress have agreed to stay on, and the company's    principals have agreed to invest at least half of their    after-tax proceeds from the sale into Fortress-managed fund    offerings. SoftBank CEO Masayoshi Sun said that his company    \"looks forward to benefiting from [Fortress'] leadership,    broad-based expertise, and world-class investment platform,\"    and the Japanese company expects Fortress to contribute toward    its overall growth objectives.  <\/p>\n<p>      Image source: Getty Images.    <\/p>\n<p>    Editas Medicine stock climbed 29% in the wake of its    announcement of a favorable intellectual property decision. The    genome-editing company said that the U.S. Patent and Trademark    Office issued a favorable decision in a case involving patents    that Editas licenses from the Broad Institute. A dispute    between MIT and Berkeley regarding the patents had threatened    to put a stop to some of the work that Editas was doing, given    that Berkeley scientists had developed technology that Broad    Institute used to evaluate gene editing in certain specific    cases. In the ruling, the U.S. PTO ruled in favor of Broad    Institute's request for no interference in fact, a legal term    of art that allows Editas to keep using CRISPR-Cas9 patents as    part of its fundamental genome-editing work. By ensuring that    Editas will be able to continue its work, the ruling gave    investors hope for future breakthroughs unhampered by the need    for further licensing.  <\/p>\n<p>    Finally, shares of Hertz Global Holdings rose 7%. The rental    car giant got good news in the form of an increased ownership    stake from well-known activist investor Carl Icahn. Icahn    reported in his quarterly disclosure of investment holdings    that he had raised his investment in Hertz to 29.3 million    shares, more than doubling his previously reported position.    That gives the activist investor about a one-third stake in    Hertz, and it will be interesting to see to what extent Icahn    pushes Hertz harder to take steps toward getting its shares    back on track. The rental car specialist's shares are down 60%    just since September, and many expect more aggressive action    from Icahn in the near future.  <\/p>\n<p>    Dan    Caplinger has no position in any stocks mentioned. The    Motley Fool owns shares of Hertz Global Holdings. The Motley    Fool has a disclosure    policy.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more here:<\/p>\n<p><a target=\"_blank\" href=\"https:\/\/www.fool.com\/investing\/2017\/02\/15\/why-fortress-investment-group-editas-medicine-and.aspx\" title=\"Why Fortress Investment Group, Editas Medicine, and Hertz Global Holdings Jumped Today - Motley Fool\">Why Fortress Investment Group, Editas Medicine, and Hertz Global Holdings Jumped Today - Motley Fool<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> The stock market continued to climb sharply on Wednesday, sending major market benchmarks to record highs yet again and propelling the Dow Jones Industrials up more than 100 points. Economic data continued to support the notion that the U.S. economy remains strong, and rising inflation levels led many to conclude that the Federal Reserve is more likely than ever to follow through on its promise to keep lifting short-term interest rates in 2017 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/why-fortress-investment-group-editas-medicine-and-hertz-global-holdings-jumped-today-motley-fool.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-208410","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/208410"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=208410"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/208410\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=208410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=208410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=208410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}